Relative risk of death in UK haemodialysis patients in relation to achieved haemoglobin from 1999 to 2005: An observational study using UK Renal Registry data incorporating 30,040 patient-years of follow-up

Nephrology Dialysis Transplantation

Volumn 25, Issue 3, 2010, Pages 914-919

  MacDougall, Iain C ^a   Tomson, Charles R V ^b   Steenkamp, Margaretha ^b   Ansell, David ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UK RENAL REGISTRY   (United Kingdom)

Author keywords

Anaemia; Haemodialysis; Haemoglobin; Mortality; UK

Indexed keywords

HEMOGLOBIN;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; POPULATION SIZE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGISTER; UNITED KINGDOM;

CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HEMOGLOBINS; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 77649227625     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp550     Document Type: Article

References (19)

1. Drüeke TB, Locatelli F, Clyne N, et al. CREATE Investigators. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 335: 2071-2084
2. Singh AK, Szczech L, Tang KL, et al. CHOIR Investigators. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 335: 2085-2098
3. Macdougall IC, Ritz E. The Normal Hematocrit Trial in dialysis patients with cardiac disease: are we any the less confused about target hemoglobin?. Nephrol Dial Transplant 1998; 13: 3030-3033
4. Levin A. Understanding recent hemoglobin trials in CKD: methods and lesson learned from CREATE and CHOIR. Nephrol Dial Transplant 2007; 22: 309-312
5. Carrera F, Macdougall IC. Hemoglobin targets: the jury is still out. Clin Nephrol 2008; 69: 8-9
6. Collins AJ, Ma JZ, Xia A, et al. Trends in anemia treatment with erythropoietin usage and patient outcomes. Am J Kidney Dis 1998; 32: S133-S141
7. Ofsthun N, Labrecque J, Lacson E, et al. The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients. Kidney Int 2003; 63: 1908-1914
8. Regidor DL, Kopple JD, Kovesdy CP, et al. Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol 2006; 17: 1181-1191
9. Levin A, Djurdjev O, Duncan J, et al. Hemoglobin at time of referral prior to dialysis predicts survival: an association of hemoglobin with long-term outcomes. Nephrol Dial Transplant 2006; 21: 370-377
10. Zhang Y, Thamer M, Stefanik K, et al. Epoetin requirements predict mortality in hemodialysis patients. Am J Kidney Dis 2004; 44: 866-876
11. Kilpatrick RD, Critchlow CW, Fishbane S, et al. Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients. Clin J Am Soc Nephrol 2008; 3: 1077-1083
12. Szczech LA, Barnhart HX, Inrig JK, et al. Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes. Kidney Int 2008; 74: 791-798
13. Renal Association Standards and Audit Subcommittee. Treatment of adult patients with renal failure: recommended standards and audit measures (2nd ed.) London: Royal College of Physicians, 1997
14. Renal Association Standards and Audit Subcommittee. Treatment of adults and children with renal failure. Standards and audit measures (3rd ed.) London: Royal College of Physicians, 2002
15. Ansell D, Feest T. UK Renal Registry Report 2002 Chapter 3
16. Strippoli GF, Tognoni G, Navaneethan SD, et al. Hemoglobin targets: we were wrong, time to move on. Lancet 2007; 369: 346-350
17. National Kidney FoundationKDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease-2007 update of hemoglobin target. Am J Kidney Dis 2007; 50: 471-530
18. Streja E, Kovesdy CP, Greenland S, et al. Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis. Am J Kidney Dis 2008; 52: 727-736
19. Health National Institute for Clinical Excellence. Anaemia management in people with chronic kidney disease September 2006